MA28359A1 - Antagonistes du recepteur a l'hydroisoindoline tachykinine - Google Patents

Antagonistes du recepteur a l'hydroisoindoline tachykinine

Info

Publication number
MA28359A1
MA28359A1 MA29265A MA29265A MA28359A1 MA 28359 A1 MA28359 A1 MA 28359A1 MA 29265 A MA29265 A MA 29265A MA 29265 A MA29265 A MA 29265A MA 28359 A1 MA28359 A1 MA 28359A1
Authority
MA
Morocco
Prior art keywords
antagonists
tachykinin receptor
hydroisoindoline
hydroisoindoline tachykinin
receptor
Prior art date
Application number
MA29265A
Other languages
English (en)
Inventor
Jaime Lynn Bunda
Robert J Devita
Jinlong Jiang
Sander G Mills
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of MA28359A1 publication Critical patent/MA28359A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA29265A 2004-01-27 2006-08-11 Antagonistes du recepteur a l'hydroisoindoline tachykinine MA28359A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53991304P 2004-01-27 2004-01-27
US56122704P 2004-04-09 2004-04-09

Publications (1)

Publication Number Publication Date
MA28359A1 true MA28359A1 (fr) 2006-12-01

Family

ID=34830494

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29265A MA28359A1 (fr) 2004-01-27 2006-08-11 Antagonistes du recepteur a l'hydroisoindoline tachykinine

Country Status (30)

Country Link
US (3) US7645790B2 (fr)
EP (1) EP1711465B1 (fr)
JP (1) JP3987100B2 (fr)
KR (1) KR20060127927A (fr)
AR (1) AR047439A1 (fr)
AT (1) ATE382034T1 (fr)
AU (1) AU2005207934B2 (fr)
BR (1) BRPI0507050A (fr)
CA (1) CA2554550C (fr)
CO (1) CO5700771A2 (fr)
CR (1) CR8522A (fr)
CY (1) CY1107167T1 (fr)
DE (1) DE602005004011T2 (fr)
DK (1) DK1711465T3 (fr)
EA (1) EA010598B1 (fr)
EC (1) ECSP066716A (fr)
ES (1) ES2297687T3 (fr)
GE (1) GEP20094691B (fr)
HR (1) HRP20080100T3 (fr)
IL (1) IL176879A0 (fr)
MA (1) MA28359A1 (fr)
NI (1) NI200600164A (fr)
NO (1) NO339041B1 (fr)
NZ (1) NZ548415A (fr)
PE (1) PE20050687A1 (fr)
PL (1) PL1711465T3 (fr)
PT (1) PT1711465E (fr)
TW (1) TWI341198B (fr)
UA (1) UA84192C2 (fr)
WO (1) WO2005073191A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI341198B (en) * 2004-01-27 2011-05-01 Merck Sharp & Dohme Hydroisoindoline tachykinin receptor antagonists
JP2008523147A (ja) 2004-12-14 2008-07-03 メルク エンド カムパニー インコーポレーテッド オクタヒドロピラノ［３，４−ｃ］ピロールタキキニン受容体拮抗薬
JP5111368B2 (ja) * 2005-06-27 2013-01-09 メルク・シャープ・エンド・ドーム・コーポレイション ヒドロイソインドリンタキキニン受容体アンタゴニスト
AU2006269383A1 (en) * 2005-07-11 2007-01-18 Merck Sharp & Dohme Corp. Process for making hydroisoindoline tachykinin receptor antagonists
CA2624440A1 (fr) * 2005-10-04 2007-04-19 Merck & Co., Inc. Polytherapie destinee au traitement de la pollakiurie, de la miction imperieuse et de l'incontinence urinaire
WO2007075528A2 (fr) * 2005-12-22 2007-07-05 Merck & Co., Inc. Antagonistes de recepteur d’octahydropyrano[3,4-c]pyrrole-tachykinine
EP1978965A2 (fr) * 2006-01-24 2008-10-15 Merck & Co., Inc. Hexahydro-3h-pyrrolizin-3-ones utiles en tant qu'antagonistes du récepteur de la tachykinine
US20100209496A1 (en) * 2006-09-06 2010-08-19 Eleni Dokou Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
EP2089019A4 (fr) * 2006-11-02 2011-05-04 Merck Sharp & Dohme Polymorphes d'un antagoniste des récepteurs de tachykinine hydro-iso-indolique
WO2008121268A1 (fr) * 2007-03-29 2008-10-09 Merck & Co., Inc. Polythérapie pour le traitement de troubles urinaires du bas appareil
ES2409093T3 (es) * 2007-04-10 2013-06-24 Merck Sharp & Dohme Corp. 4-(octahidro-2H-isoindol-2-il)-1,3-oxazol-4-ona como antagonistas de receptor de taquicinina
JP5812500B2 (ja) 2010-04-30 2015-11-17 メルク・シャープ・エンド・ドーム・コーポレイション 新規なβ３アドレナリン作動性受容体アゴニスト
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
WO2013004766A1 (fr) 2011-07-04 2013-01-10 Ferrari Giulio Antagonistes des récepteurs nk-1 pour traiter une néovascularisation cornéenne
BR112015031724A2 (pt) * 2013-06-24 2017-07-25 Tigercat Pharma Inc uso do antagonista do receptor nk-1 serlopitant em pruridos
US8906951B1 (en) 2013-06-24 2014-12-09 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
US9198898B2 (en) 2013-06-24 2015-12-01 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
IL312486B2 (en) 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
CN121221782A (zh) 2017-06-30 2025-12-30 傲拓神经科学公司 用于治疗抑郁的nk-1拮抗剂组合物和方法
CN111918647A (zh) 2018-02-26 2020-11-10 圣拉斐尔医院有限公司 用于治疗眼痛的nk-1拮抗剂
WO2021180885A1 (fr) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Traitement d'une déficience en cellules souches
AU2021246889A1 (en) 2020-04-03 2022-10-13 Nerre Therapeutics Limited An NK-1 receptor antagonist for treating a disease selecting from sepsis, septic shock,, acute respiratory distress syndrome (ARDS) or multiple organ dysfunction syndrome (MODS)
CA3177477A1 (fr) 2020-06-02 2021-12-09 Nerre Therapeutics Limited Antagonistes du recepteur de la neurokinine (nk)-1 destines a etre utilises dans le traitement d'etats de fibrose pulmonaire favorises par une lesion mecanique des poumons

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650142A (en) * 1995-09-27 1997-07-22 Church & Dwight Co., Inc. Bicarbonate-containing deodorant cosmetic stick compositions
AU722883B2 (en) * 1995-10-18 2000-08-10 Merck & Co., Inc. Cyclopentyl tachykinin receptor antagonists
US7468437B2 (en) 2003-09-30 2008-12-23 Merck & Co., Inc. Phenyl pyrrolidine ether tachykinin receptor antagonists
TWI341198B (en) * 2004-01-27 2011-05-01 Merck Sharp & Dohme Hydroisoindoline tachykinin receptor antagonists

Also Published As

Publication number Publication date
KR20060127927A (ko) 2006-12-13
ECSP066716A (es) 2006-10-31
HK1100937A1 (zh) 2007-10-05
JP3987100B2 (ja) 2007-10-03
ATE382034T1 (de) 2008-01-15
US20070161695A1 (en) 2007-07-12
CA2554550A1 (fr) 2005-08-11
PE20050687A1 (es) 2005-09-27
UA84192C2 (en) 2008-09-25
AU2005207934A1 (en) 2005-08-11
CY1107167T1 (el) 2012-10-24
US20080280966A1 (en) 2008-11-13
US20050165083A1 (en) 2005-07-28
PL1711465T3 (pl) 2008-05-30
EA010598B1 (ru) 2008-10-30
US7345083B2 (en) 2008-03-18
TWI341198B (en) 2011-05-01
JP2007519728A (ja) 2007-07-19
BRPI0507050A (pt) 2007-06-12
DK1711465T3 (da) 2008-03-31
AU2005207934B2 (en) 2010-11-25
DE602005004011T2 (de) 2008-12-11
EP1711465B1 (fr) 2007-12-26
CA2554550C (fr) 2011-05-03
NO20063810L (no) 2006-10-26
EA200601378A1 (ru) 2007-02-27
US7217731B2 (en) 2007-05-15
HRP20080100T3 (en) 2008-04-30
ES2297687T3 (es) 2008-05-01
US7645790B2 (en) 2010-01-12
PT1711465E (pt) 2008-02-25
NI200600164A (es) 2007-05-29
DE602005004011D1 (de) 2008-02-07
TW200534850A (en) 2005-11-01
CO5700771A2 (es) 2006-11-30
EP1711465A1 (fr) 2006-10-18
WO2005073191A1 (fr) 2005-08-11
NO339041B1 (no) 2016-11-07
IL176879A0 (en) 2006-10-31
NZ548415A (en) 2009-11-27
GEP20094691B (en) 2009-05-25
CR8522A (es) 2007-06-06
AR047439A1 (es) 2006-01-18

Similar Documents

Publication Publication Date Title
MA28359A1 (fr) Antagonistes du recepteur a l'hydroisoindoline tachykinine
EP1725238A4 (fr) Antagonistes du recepteur muscarinique a l'acetylcholine m 3
NO20051871D0 (no) Opioid reseptorantagonister
EP2049110A4 (fr) Diazépans pontés antagonistes du récepteur de l'oréxine
ATE413400T1 (de) Cgrp-rezeptorantagonisten
DK1682142T3 (da) M3-muscarin-acetylcholin-receptor-antagonister
MA29034B1 (fr) Posologie d'un agoniste du recepteur s1p
EP1765805A4 (fr) Antagonistes des recepteurs du cgrp
EP1641781A4 (fr) Antagonistes du recepteur cgrp de benzodiazepine
DK1501809T3 (da) Trizolderivater som tachykininreceptorantagonister
MA28631B1 (fr) Antagonistes des recepteurs muscariniques de l'acetylcholine
EP1444251A4 (fr) Peptides cycliques comme antagonistes du recepteur couple a la proteine g
EP1871752A4 (fr) Antagonistes du récepteur de l' orexine de type amidopropoxyphényle
EP1814550A4 (fr) Antagonistes du recepteur 1 de n-sulfonylpiperidine cannabinoide
EP1846455A4 (fr) Anticorps de recepteur de l'oncostatine m
EP1827421A4 (fr) Modulateurs du recepteur de l'oestrogene
IS8522A (is) Ný M3 múskarínasetýlkólínviðtakamótlyf
IS8515A (is) Ný M3 múskarínasetýlkólínviðtakamótlyf
EP1799672A4 (fr) Antagonistes du recepteur de cgrp
EP1813875A4 (fr) Unite interieure d'un climatiseur
MA28363A1 (fr) Antagonistes des recepteurs muscariniques de l'acetylcholine
EP1819342A4 (fr) Antagonistes de récepteurs de tachykinine de type quinoline
EP2076285A4 (fr) Antagonistes d'anticorps du récepteur 1 de l'interleukine-13
EP1819677A4 (fr) Antagonistes du recepteur de tachykinine de 8-phenyl-5,6,7,8-hydroquinoline
EP1951228A4 (fr) Antagonistes du recepteur cgrp biclyclique de spirohydantoine